A chemist based at the University of Copenhagen has just taken out a patent for a drug that can make previously multidrug-resistant bacteria responsive to antibiotics once again.
Jørn Bolstad and his chemist colleagues hope that the substance will soon be able to tackle the tremendous problems associated with multidrug resistant tuberculosis (MDR-TB). But first, they need to find investors interested in getting the substance onto the market.
Before the development of penicillin, people dropped like flies in response to minor infections: in the lungs, in small cuts. Even pimples could grow to boils that killed. But one of the main killers prior to the discovery of antibiotics was tuberculosis.
The deadly infectious disease that typically affects the lungs has returned. It has developed a resistance to the majority of antibiotics that would otherwise kill the tuberculosis bacteria. Currently, the disease does not pose an imminent threat to Denmark or the West. However, resistant strains of the bacteria are nearing the region’s borders. This is one of the reasons why doctors around the world are busy trying to solve the problem of drug resistance.
The bacteria shed killing substances
While those bacteria that have developed a resistance remain vulnerable to antibiotics, they have developed an ability to shed bacteria killing substances before any damage is done to them. Colloquially, this is referred to as pooping the substance out, but the scientific formulation is that these bacteria activate an efflux pump.
Jørn Bolstad Christensen has isolated a substance able to block the efflux pump so that an antibiotic remains in bacteria until the bacteria dies.
You could say that we cure bacteria of their resistance, and slay them with antibiotics, explains Associate Professor Jørn Bolstad Christensen.
From antipsychotic to killing bacteria
Working with doctors Jette Kristiansen from the University of Southern Denmark and Oliver Hendricks from the King Christian X’s Hospital for Rheumatic Diseases in Gråsten, Denmark, Jørn Bolstad Christensen discovered that Thioridazin, an antipsychotic drug, was able to kill bacteria without any noticeably harmful effects upon humans. Still, the chemists had an idea that could make the substance more benign.
We now have a substance that is able to block the bacteria’s efflux pump. At very most, recipients of the medication may become slightly sluggish. This is also because very small doses are needed to affect the bacteria, says Jørn Bolstad Christensen.
Researchers hope for quick approval
Because Thioridazin is an approved drug, the research team hopes that the new anti-resistance medication, JEK 47, will be approved without going through the entire process that new pharmaceuticals are typically subjected to. If this is the case, JEK 47 will most likely be a cheap medication that a pharmaceuticals manufacturer could release quickly. However if an investor does not show interest, Christensen is certain about his next step.
The Latest on: Antibiotic resistance
via Google News
The Latest on: Antibiotic resistance
- The silent pandemic of antibiotic resistanceon January 21, 2021 at 8:02 pm
A South African doctor’s prescription to stop poorer countries losing access to many of modern medicine’s advances ...
- Health officials worried pandemic may be contributing to spike in antibiotic-resistant 'superbugs'on January 21, 2021 at 3:51 pm
A new study published in the Clinical Infectious Diseases journal analyzed thousands of hospitalized kids across the country who had been prescribed antibiotics in 2016 and 2017. It found 26% either ...
- Antibiotic resistance may spread even more easily than expectedon January 21, 2021 at 4:49 am
Pathogenic bacteria in humans are developing resistance to antibiotics much faster than expected. Now, computational research at Chalmers University of Technology, Sweden, shows that one reason could ...
- CBD Destroys Antibiotic-Resistant Bacteria Such as Gonorrhea, Study Findson January 21, 2021 at 12:30 am
For the first time ever, researchers at the University of Queensland have found how cannabis can provide a solution to antibiotic-resistant bacteria. A non-psychoactive cannabinoid known as ...
- Antibiotic resistance may be more widespread than previously expectedon January 20, 2021 at 11:40 pm
Pathogenic bacteria in humans are developing resistance to antibiotics much faster than expected. Now, computational research at Chalmers University of Technology, Sweden, shows that one reason could ...
- Overuse of antibiotics for meat production drives resistance in humanson January 20, 2021 at 8:05 pm
Mention antibiotic resistance and few people would link what is increasingly being recognised as a growing global health crisis with a Big Mac. But in the US, animals farmed for food account for most ...
- Study: Combination antibiotics may fuel inappropriate use globallyon January 20, 2021 at 3:48 pm
The use of fixed-dose combination antibiotics needs to reconsidered, given questions about their efficacy and safety, as well as their possible role in increasing antibiotic resistance, according to t ...
- Origins of Antibiotic Resistanceon January 20, 2021 at 8:09 am
As the use of antibiotics increases, as does antibiotic resistance. It is vital to understand how antibiotic resistance has emerged and the ways to prevent it.
- CBD Kills Antibiotic-Resistant Bacteria Such As Gonorrhea, According To Studyon January 20, 2021 at 7:10 am
Antibiotic resistance currently poses a major threat to global healthcare systems, but a new study in the journal Nature Communications Biology suggests th ...
- Unlocking 'the shape of water' in mechanisms of antibiotic resistanceon January 19, 2021 at 5:57 pm
Researchers captured and comparted hi-res images of ribosome structures from sensitive and resistant bacteria and report that a water molecule needed for antibiotic binding was not present in the ...
via Bing News